. Author manuscript; available in PMC: 2022 Jan 1.

Published in final edited form as: Prostaglandins Leukot Essent Fatty Acids. 2020 Dec 5;164:102219. doi: 10.1016/j.plefa.2020.102219

Table 1.

Baseline characteristics of study participants.

	Placebo (n=10)	EPA 1 g/d (n=11)	EPA 2 g/d (n=11)	EPA 4 g/d (n=10)
Gender, M/F	2/8	3/8	3/8	4/6
Age, y¹	52±13	43±17	47±15	46±14
BMI, kg/m^{2 2}	38.8 (10.7)	33.2 (5.2)	34.3 (13.0)	35.0 (10.7)
hs-CRP, μg/mL²	6.3 (11.0)	6.6 (8.8)	6.4 (3.0)	3.9 (1.1)
IDS-C30¹	37.8±8.2	37.7±6.0	33.7±7.7	34.8±8.5

mean±SD;

median (interquartile range: 75^th – 25^th percentile)

BMI: body mass index; hs-CRP: high sensitivity C reactive protein; IDS-C30: Inventory of depressive symptomatology – 30 items